GLUCAGONRECEPTORANTAGONISTER, FREMSTILLING OG TERAPEUTISKE ANVENDELSER DERAF

The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions...

Full description

Saved in:
Bibliographic Details
Main Authors LI, JIANKE, ZHU, GUOXIN, CONNER, SCOTT, EUGENE
Format Patent
LanguageDanish
Published 03.09.2012
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
Bibliography:Application Number: DK20060850109T